Health Systems Strengthening Project Impact Evaluation 2015, Baseline Survey
Liberia, 2013 - 2015
Get MicrodataCreated on
Jan 16, 2021
Last modified
Jan 16, 2021
Page views
163547
(ind_id1)
Data file: p_do_1
Overview
Valid:
952
Invalid:
0
Type:
Discrete
Start:
1731
End:
1735
Width:
5
Range:
-
Format:
character
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| 23 | 1 |
0.1%
|
|
| 59 | 1 |
0.1%
|
|
| 96 | 4 |
0.4%
|
|
| ER01 | 4 |
0.4%
|
|
| ER02 | 10 |
1.1%
|
|
| ER03 | 11 |
1.2%
|
|
| ER04 | 4 |
0.4%
|
|
| ER05 | 11 |
1.2%
|
|
| ER06 | 28 |
2.9%
|
|
| ER07 | 8 |
0.8%
|
|
| ER08 | 7 |
0.7%
|
|
| ER09 | 11 |
1.2%
|
|
| ER10 | 20 |
2.1%
|
|
| ER11 | 5 |
0.5%
|
|
| ER12 | 5 |
0.5%
|
|
| ER13 | 11 |
1.2%
|
|
| ER14 | 33 |
3.5%
|
|
| ER15 | 7 |
0.7%
|
|
| ER16 | 9 |
0.9%
|
|
| ER17 | 2 |
0.2%
|
|
| ER18 | 15 |
1.6%
|
|
| ER19 | 5 |
0.5%
|
|
| ER20 | 12 |
1.3%
|
|
| ER21 | 2 |
0.2%
|
|
| ER22 | 1 |
0.1%
|
|
| ER23 | 2 |
0.2%
|
|
| ER24 | 8 |
0.8%
|
|
| ER25 | 6 |
0.6%
|
|
| ER26 | 1 |
0.1%
|
|
| ER27 | 3 |
0.3%
|
|
| ER28 | 5 |
0.5%
|
|
| ER29 | 1 |
0.1%
|
|
| ER30 | 3 |
0.3%
|
|
| ER31 | 1 |
0.1%
|
|
| ER32 | 3 |
0.3%
|
|
| ER33 | 3 |
0.3%
|
|
| ER34 | 6 |
0.6%
|
|
| ER36 | 1 |
0.1%
|
|
| ER37 | 1 |
0.1%
|
|
| ER40 | 1 |
0.1%
|
|
| ER404 | 1 |
0.1%
|
|
| ER41 | 2 |
0.2%
|
|
| ER47 | 1 |
0.1%
|
|
| ER58 | 1 |
0.1%
|
|
| ER62 | 1 |
0.1%
|
|
| ER66 | 2 |
0.2%
|
|
| ER72 | 1 |
0.1%
|
|
| ER73 | 1 |
0.1%
|
|
| ER75 | 2 |
0.2%
|
|
| ER82 | 1 |
0.1%
|
|
| ER83 | 1 |
0.1%
|
|
| ER86 | 1 |
0.1%
|
|
| ER87 | 1 |
0.1%
|
|
| ERO1 | 1 |
0.1%
|
|
| GN06 | 5 |
0.5%
|
|
| GN12 | 5 |
0.5%
|
|
| GN26 | 1 |
0.1%
|
|
| GN30 | 10 |
1.1%
|
|
| GN32 | 5 |
0.5%
|
|
| GN33 | 2 |
0.2%
|
|
| GN35 | 7 |
0.7%
|
|
| GN45 | 25 |
2.6%
|
|
| NA | 1 |
0.1%
|
|
| OB03 | 1 |
0.1%
|
|
| OB15 | 3 |
0.3%
|
|
| PE | 1 |
0.1%
|
|
| PE01 | 43 |
4.5%
|
|
| PE02 | 7 |
0.7%
|
|
| PE03 | 22 |
2.3%
|
|
| PE04 | 18 |
1.9%
|
|
| PE05 | 1 |
0.1%
|
|
| PE06 | 3 |
0.3%
|
|
| PE07 | 3 |
0.3%
|
|
| PE08 | 22 |
2.3%
|
|
| PE09 | 8 |
0.8%
|
|
| PE10 | 19 |
2%
|
|
| PE11 | 2 |
0.2%
|
|
| PE12 | 42 |
4.4%
|
|
| PE13 | 2 |
0.2%
|
|
| PE14 | 38 |
4%
|
|
| PE15 | 57 |
6%
|
|
| PE16 | 15 |
1.6%
|
|
| PE17 | 28 |
2.9%
|
|
| PE172 | 1 |
0.1%
|
|
| PE18 | 6 |
0.6%
|
|
| PE20 | 11 |
1.2%
|
|
| PE22 | 3 |
0.3%
|
|
| PE23 | 31 |
3.3%
|
|
| PE24 | 33 |
3.5%
|
|
| PE25 | 13 |
1.4%
|
|
| PE27 | 5 |
0.5%
|
|
| PE28 | 16 |
1.7%
|
|
| PE29 | 4 |
0.4%
|
|
| PE30 | 1 |
0.1%
|
|
| PE31 | 2 |
0.2%
|
|
| PE32 | 1 |
0.1%
|
|
| PE33 | 1 |
0.1%
|
|
| PE34 | 2 |
0.2%
|
|
| PE35 | 4 |
0.4%
|
|
| PE36 | 19 |
2%
|
|
| PE37 | 5 |
0.5%
|
|
| PE38 | 1 |
0.1%
|
|
| PE39 | 12 |
1.3%
|
|
| PE53 | 41 |
4.3%
|
|
| PE55 | 3 |
0.3%
|
|
| PE57 | 1 |
0.1%
|
|
| PE58 | 10 |
1.1%
|
|
| PE59 | 11 |
1.2%
|
|
| PE63 | 2 |
0.2%
|
|
| PE71 | 2 |
0.2%
|
|
| PE74 | 14 |
1.5%
|
|
| SU02 | 2 |
0.2%
|
|
| SU05 | 7 |
0.7%
|
|
| SU06 | 1 |
0.1%
|
|
| SU07 | 2 |
0.2%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.